Marlowe plc (LON:MRL - Get Free Report) hit a new 52-week high during trading on Wednesday . The stock traded as high as GBX 348.40 ($4.56) and last traded at GBX 346 ($4.53), with a volume of 896912 shares. The stock had previously closed at GBX 340.50 ($4.46).
Wall Street Analyst Weigh In
MRL has been the topic of several analyst reports. Berenberg Bank reiterated a "buy" rating and set a GBX 710 ($9.29) price target on shares of Marlowe in a research report on Wednesday, August 21st. Royal Bank of Canada reiterated an "outperform" rating and issued a GBX 690 ($9.03) target price on shares of Marlowe in a research note on Thursday, August 1st.
Check Out Our Latest Research Report on Marlowe
Marlowe Stock Performance
The firm has a market capitalization of £304.48 million, a PE ratio of -2,478.57 and a beta of 0.44. The company has a quick ratio of 0.80, a current ratio of 1.24 and a debt-to-equity ratio of 58.99. The company has a 50-day moving average of GBX 423.51 and a 200 day moving average of GBX 473.79.
Insider Activity
In related news, insider Peter M. R. Gaze bought 15,000 shares of the company's stock in a transaction on Friday, September 27th. The stock was acquired at an average cost of GBX 309 ($4.04) per share, for a total transaction of £46,350 ($60,659.60). Corporate insiders own 25.19% of the company's stock.
Marlowe Company Profile
(
Get Free Report)
Marlowe plc provides compliance services and software in the United Kingdom. The company operates in two segments, Governance, Risk and Compliance; and Testing, and Inspection and Certification. It offers health and safety consultancy, risk and audit assessments, environmental, contractor management, and training services; and health and safety support services.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Marlowe, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Marlowe wasn't on the list.
While Marlowe currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
